Literature DB >> 11428850

Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes?

I Lönnberg, C Berne, G Nilsson, J Leppert.   

Abstract

AIMS: To investigate the prevalence of diabetes mellitus in patients with acute myocardial infarction and to determine whether casual blood glucose and haemoglobin A1c measured at admission could be used to diagnose diabetes mellitus. METHODS AND
RESULTS: A prospective study that included all patients with acute myocardial infarction hospitalized during a one-year period at a coronary care unit. Casual blood glucose was measured at admission, fasting blood glucose during the hospital stay and, if necessary for classification, 2-3 months after discharge. Haemoglobin A1c was measured once at admission. Of 305 patients included in the study, 285 could be classified into three groups: 21% of these had previously diagnosed diabetes, 4% had newly diagnosed diabetes and the remaining patients were categorized as non-diabetic. Casual blood glucose >or=11.1 mmol x l(-1)at admission was found in 12 patients with no previously known diabetes, but diabetes mellitus was confirmed in only six of these patients. Haemoglobin A1c showed considerable overlapping of values between the three groups of patients (i.e. patients with known diabetes mellitus, patients with newly diagnosed diabetes mellitus and non-diabetics).
CONCLUSION: One of four patients with acute myocardial infarction had diabetes mellitus. Increased casual blood glucose at admission was not a reliable measure to establish a diagnosis of diabetes and thus follow-up measures were necessary. Haemoglobin A1c was found to be an unreliable measure in the verification of diabetes. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11428850     DOI: 10.1053/euhj.2000.2445

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  15 in total

Review 1.  Hyperglycemia in nondiabetic patients presenting with acute myocardial infarction.

Authors:  Binita Shah; Nicholas S Amoroso; Steven P Sedlis
Journal:  Am J Med Sci       Date:  2012-04       Impact factor: 2.378

Review 2.  Stem cells in the diabetic infarcted heart.

Authors:  Carley E Glass; Pawan K Singal; Dinender K Singla
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

3.  Raised Glycated Hemoglobin (HbA1c) Level as a Risk Factor for Myocardial Infarction in Diabetic Patients: A Hospital-Based, Cross-Sectional Study in Peshawar.

Authors:  Saud Azhar; Fahd Zafar Khan; Shahmir Tariq Khan; Bushra Iftikhar
Journal:  Cureus       Date:  2022-06-07

4.  Impact of Admission Glucose on Non-Diabetic Patients with ST-Segment Elevation Myocardial Infarction Treated with Percutaneous Coronary Intervention: A Meta-Analysis.

Authors:  Zhen-Xuan Hao; Yang Liu; Dan-Li Wang; Wen-Jie Han; Lei Wu; Heng-Liang Liu
Journal:  Acta Cardiol Sin       Date:  2016-03       Impact factor: 2.672

Review 5.  The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromes.

Authors:  Abhinav Goyal; John L Petersen; Kenneth W Mahaffey
Journal:  Curr Cardiol Rep       Date:  2004-07       Impact factor: 2.931

6.  Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome.

Authors:  C Weston; L Walker; J Birkhead
Journal:  Heart       Date:  2007-05-13       Impact factor: 5.994

Review 7.  The oral glucose tolerance test for the diagnosis of diabetes mellitus in patients during acute coronary syndrome hospitalization: a meta-analysis of diagnostic test accuracy.

Authors:  Yicong Ye; Hongzhi Xie; Xiliang Zhao; Shuyang Zhang
Journal:  Cardiovasc Diabetol       Date:  2012-12-27       Impact factor: 9.951

8.  Value of oral glucose tolerance test in the acute phase of myocardial infarction.

Authors:  Agata Bronisz; Marek Kozinski; Przemyslaw Magielski; Tomasz Fabiszak; Joanna Gierach; Iwona Swiatkiewicz; Adam Sukiennik; Aldona Kubica; Marek Bronisz; Zofia Grabczewska; Anna Sinkiewicz; Roman Junik; Jacek Kubica
Journal:  Cardiovasc Diabetol       Date:  2011-03-11       Impact factor: 9.951

Review 9.  Hyperglycaemia in critically ill patients: marker or mediator of mortality?

Authors:  Anouk M Corstjens; Iwan C C van der Horst; Jan G Zijlstra; A B Johan Groeneveld; Felix Zijlstra; Jaap E Tulleken; Jack J M Ligtenberg
Journal:  Crit Care       Date:  2006-06-27       Impact factor: 9.097

10.  Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study.

Authors:  Nitin Narayan Gholap; Rajnikant Laxmishanker Mehta; Leong Ng; Melanie J Davies; Kamlesh Khunti; Iain B Squire
Journal:  BMJ Open       Date:  2012-09-25       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.